Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
EGFR mutation testing and first line treatment of patients with advanced NSCLC and positive EGFR mutation status: results from a German registry.

Eberhardt, W., Thomas, M., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, P., Zirrgiebel, U., Schütte, W., 2011.

EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Poster 133), 664.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: EMCC (ESMO) / Journal: -
REASON
2011
REASON: A Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV.

Dietel, M., Schütte, W., Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Schirmacher, P., 2011.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGP / Journal: -
REASON
2011
First line therapy with Bendamustine in advanced indolent Non-Hodgkin Lymphoma in treatment routine – interim analysis of the non-interventional study Be-1st.

Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Grass, J., Straßl, L., 2011.

Onkologie 34 (suppl.6)(P891), 268. doi:10.1159/000333305

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
Be-1st
2011
Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial.

Bartlett, J.M.S., Brookes, C.L., Robson, T., van de Velde, C.J.H., Billingham, L.J., Campbell, F.M., Grant, M., Hasenburg, A., Hille, E.T.M., Kay, C., Kieback, D.G., Putter, H., Markopoulos, C., Kranenbarg, E.M.-K., Mallon, E.A., Dirix, L., Seynaeve, C., Rea, D., 2011.

J Clin Oncol 29, 1531–1538. doi:10.1200/JCO.2010.30.3677

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Journal of Clinical Oncology
TEAM
2011
Tumorregister Lymphatische Neoplasien (TLN) der niedergelassenen Hämato-/Onkologen in Deutschland.

Abenhardt, W., Knauf, W., 2011.

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: Lymphom-Meeting / Journal: -
TLN
2011
Interim analysis of the German non-interventional post marketing surveillance study (NIS) on Quality of Life (QoL) of capecitabine in patients with metastatic breast cancer (MBC).

Zaiss, M., Fuxius, S., Lerchenmueller, C., Hahn, L., Luhn, B., Marschner, N., Steffens, C.C., Soeling, U., Mueller, V., 2010.

Ann Oncol 21 (suppl 8)(314P), viii108. doi:10.1093/annonc/mdq517

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
Xeloda-NIS
2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.

van Nes, J.G.H., Seynaeve, C., Jones, S., Markopoulos, C., Putter, H., van de Velde, C.J.H., Hasenburg, A., Rea, D.W., Vannetzel, J.-M., Dirix, L., Hozumi, Y., Kerin, M.J., Kieback, D.G., Meershoek-Klein Kranenbarg, W.M., Hille, E.T.M., Nortier, J.W.R., 2010.

Br J Surg 97, 671–679. doi:10.1002/bjs.6962

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: British Journal of Surgery
TEAM
2010
Trends in surgical treatment of breast cancer. Data from a clinical registry.

Tesch, H., Rauh, J., Fietz, T., Overkamp, F., Hartmann, H., Marschner, N., 2010.

Onkologie 33 (suppl 6)(P194), 54. doi:10.1159/000321407

Abstract

Download

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
TMK
2010
HEXAFIL: Non-interventional study for supportive treatment of chemotherapy induced neutopenia with Filgrastim HEXAL®.

Tesch, H., Indorf, M., Hartmann, U., 2010.

Onkologie 33 (suppl 6)(P241), 71. doi:10.1159/000321409

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
HEXAFIL
2010
Treatment of tumor induced iron deficiency with ferric carboxymaltose (FCM, ferinject®)

Steinmetz, T., Tschechne, B., Selak, E., Kellner, T., Schröder, D., Marschner, N., Virgin, G., Kaldeweier, A., 2010.

Onkologie 33 (suppl 6)(P250), 74. doi:10.1159/000321409

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
Ferinject-NIS
2010